Home Newsfeeds United Airlines, Emirates Announce Codeshare Agreement

United Airlines, Emirates Announce Codeshare Agreement

-Reuters

byBenzinga Newsdesk

September 14, 2022

1 minute read

-Reuters

Vaccitech Says Prime-boost Vaccine Study Data In Women With Low-grade HPV Lesions Is ‘Promising Step In Right Direction’

By Vandana Singh

March 20, 10:44 AM

Vaccitech plc (NASDAQ:VACC) announced topline interim data from the HPV001 Phase 1b/2 clinical trial of VTP-200 in women with low-grade cervical…

VACC

News

Titan Medical Granted Patent Covering User Experience, Further Enhancing Its Intellectual Property In Robotic Assisted Surgery

By Benzinga Newsdesk

December 13, 8:35 AM

Titan Medical Inc. (NASDAQ:TMDI, TSX:TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced

TMDI

FDA
News

UPDATE: Clovis Oncology Says FDA Maintains Their Recommendation That Co. Wait For More Mature Overall Survival Data To Submit SNDA

By Michael Horton

July 6, 4:37 PM

-Reuters

CLVS

TUKYSA In Combination With Antibody-Drug Conjugate Ado-Trastuzumab Emtansine Improves Progression-Free Survival In Patients With Previously Treated HER2-Positive Metastatic Breast Cancer

By Benzinga Newsdesk

December 6, 9:19 AM

-- Results of Phase 3 HER2CLIMB-02 trial featured in an oral presentation and official press program at the 2023 San Antonio Breast Cancer Symposium --Seagen Inc. (NASDAQ:SGEN) today announced data from the Phase 3

SGEN

United Airlines, Emirates Announce Codeshare Agreement

Related Posts

Vaccitech Says Prime-boost Vaccine Study Data In Women With Low-grade HPV Lesions Is ‘Promising Step In Right Direction’

Titan Medical Granted Patent Covering User Experience, Further Enhancing Its Intellectual Property In Robotic Assisted Surgery

UPDATE: Clovis Oncology Says FDA Maintains Their Recommendation That Co. Wait For More Mature Overall Survival Data To Submit SNDA

TUKYSA In Combination With Antibody-Drug Conjugate Ado-Trastuzumab Emtansine Improves Progression-Free Survival In Patients With Previously Treated HER2-Positive Metastatic Breast Cancer